Brand Performance Analytics: Know Why Your Numbers Changed Before Anyone Asks
Market share moved. Your job is to explain why—and what to do about it. AI-powered brand analytics delivers share decomposition, competitive intelligence, and root cause analysis in natural language, on demand.
Every week, someone asks "Why did share drop at Walmart?" or "What's driving the competitive gain in the Northeast?" The answer requires pulling syndicated data, reconciling with retailer numbers, building decomposition models, and chasing down the signal in the noise. By the time you have the answer, the conversation has moved on—and the insight is stale.
What is AI-Powered Brand Performance Analytics for CPG?
Brand performance analytics is an AI-powered approach that unifies syndicated data, retailer data, and internal metrics to help CPG commercial teams understand what's driving market share changes and competitive dynamics.
Unlike traditional reporting that shows what happened but not why, AI-powered brand analytics automatically decomposes share movements into distribution, velocity, and price components—explaining whether you're losing share because competitors gained shelf space, because your velocity slowed, or because price gaps widened. It monitors competitive activity continuously, flags emerging threats before quarterly reviews, and generates the "why" narratives that leadership demands.
Tellius is a brand performance analytics platform purpose-built for CPG teams—combining conversational analytics for instant answers with agentic analytics that monitors brand health and alerts you when metrics move.
The Problem
Everyone wants to know why share moved. No one has time to figure it out.
You're spending 80% of your time pulling data and 20% analyzing it. Share decomposition requires reconciling Nielsen, retailer data, and internal numbers—a process that takes days. Competitive intelligence surfaces at quarterly reviews, weeks after threats emerged. And when leadership asks "Why did we lose a point of share?", the honest answer is "Give me a week and I'll tell you."
Brand teams operate without real-time share drivers, competitive visibility, or root cause explanations
Share decomposition takes days because breaking down share change into distribution, velocity, and price components requires pulling syndicated data, aligning it with retailer data, and building attribution models manually.
Competitive threats surface too late because monitoring competitor share, distribution gains, new launches, and pricing moves across categories and retailers requires constant manual tracking that no one has capacity for.
"Why" questions go unanswered because traditional reporting shows what happened (share down 0.5 points) but not why (velocity decline in top 3 accounts driven by promotional gap versus competitor).
New product performance is a black box because tracking launch velocity, distribution build, trial-to-repeat conversion, and source-of-volume requires stitching together multiple data sources that don't naturally connect.
Price/volume/mix analysis is a manual project because decomposing revenue or share change into price, volume, and mix components requires building custom Excel models for each analysis request.
Brand health metrics are disconnected from sales because awareness, consideration, and equity tracking live in separate systems from market performance data, so connecting brand health to business results is guesswork.

What good brand performance analytics looks like (without the manual decomposition)

AI-Powered Share Decomposition: Automated breakdown of share movements into drivers—distribution gains/losses, velocity changes, price gap shifts, and mix effects—delivered in hours, not days.

Agentic Competitive Intelligence: AI agents monitor competitive dynamics continuously—flagging share shifts, distribution gains, new item velocity, and pricing changes before quarterly reviews.

Automated Root Cause Analysis: AI explains why metrics changed, not just that they changed—connecting share movements to specific drivers, accounts, and time periods.

New Product Tracking Dashboard: Unified view of launch performance—velocity versus plan, distribution build rate, repeat purchase patterns, and cannibalization versus conquest.

Automated P/V/M Decomposition: AI decomposes share and revenue changes into price, volume, and mix effects automatically—available on demand for any brand, retailer, or time period.

Integrated Brand Health View: Brand tracking metrics connected to sales performance—see how awareness, consideration, and equity trends correlate with share and velocity movements.
The results
The ROI of knowing why before anyone asks
80%+
4+
weeks
90%+
$5M+

Why tellius
How AI Transforms Brand Performance Analytics

Unify
Connect syndicated data (Nielsen, Circana), retailer data (Walmart Luminate, Kroger 84.51°), panel data (Numerator), and internal shipment/spend data into one governed view of brand performance across channels and accounts.

Explain
AI decomposes share changes into drivers, explains competitive dynamics, and generates the "why" narratives that leadership demands. Ask "Why did we lose share at Target?" and get root cause analysis, not just charts.

Act
Agentic workflows monitor brand metrics continuously—flagging share erosion, competitive gains, velocity declines, and pricing threats before they become quarterly surprises.
Questions & Answers
Real Questions from CPG Brand & Commercial Teams
Part 1: Brand Performance Fundamentals
Understand what brand performance analytics is, why it matters, and what problems it solves.
1. What is brand performance analytics and how does AI change it?
Brand performance analytics measures how your brands are performing in market—tracking market share, velocity, distribution, pricing, and competitive position. Traditionally, this requires analysts to pull syndicated data, reconcile with retailer-specific data, build decomposition models, and create reports—a process that consumes days for each analysis cycle.
AI changes brand performance analytics in three ways. First, it automates data integration and reconciliation, eliminating the manual work that consumes most analysis time. Second, it enables continuous monitoring rather than periodic reporting—flagging changes when they happen, not weeks later. Third, it provides automated explanation—decomposing what changed into why it changed without requiring manual model-building.
The shift is from brand analytics as a reactive reporting function to brand intelligence as a continuous, proactive capability.
4. How is brand performance different from brand health?
Brand performance measures market results—share, sales, velocity, distribution. These are outcome metrics that show how your brand is performing commercially.
Brand health measures consumer perceptions—awareness, consideration, preference, equity. These are leading indicators that predict future performance. Strong brand health typically translates to strong brand performance over time.
The connection between brand health and brand performance isn't always immediate or linear. A brand can have strong awareness but weak conversion to purchase. Or strong loyalty among existing buyers but limited awareness among potential new buyers.
AI-powered analytics connects both perspectives—showing how changes in brand health metrics correlate with changes in market performance, and identifying where brand investment might be driving (or failing to drive) commercial results.
5. Who uses brand performance analytics and what questions do they ask?
Brand Managers and Marketing Directors use brand analytics to track performance, understand competitive dynamics, and inform marketing investment decisions. Their questions include "Why did share decline last period?" and "Which competitors are gaining and why?"
Sales and Key Account Managers use brand analytics to prepare for retailer conversations and understand account-level performance. They ask "How is our brand performing at Kroger versus Target?" and "Why did velocity drop at Walmart?"
Commercial Leadership uses brand analytics for business reviews and strategic decisions. They need summary views of brand health across the portfolio and answers to "Which brands are at risk?" and "Where should we invest?"
Revenue Growth Management uses brand analytics to understand how pricing, promotion, and assortment decisions affect brand performance. They ask "How did the price increase affect share?" and "What's the ROI of our brand investment?"
6. What data sources feed brand performance analytics?
Effective brand performance analytics requires four data categories. First, syndicated market data from Nielsen or Circana—category sales, share, distribution, and velocity metrics across markets and retailers. This is the foundation for competitive benchmarking.
Second, retailer-specific data from platforms like Walmart Luminate, Kroger 84.51°, or Target Roundel—store-level performance, shopper insights, and retailer-specific metrics that syndicated data aggregates.
Third, panel and shopper data from Numerator, NIQ Homescan, or retailer loyalty programs—household-level purchase behavior, brand switching, and source-of-volume analysis.
Fourth, internal data including shipments, trade spend, marketing investment, and brand health tracking—connecting market performance to actions and investments.
The integration challenge is reconciling these sources, which define markets, brands, and time periods differently.
7. How is CPG brand analytics different from pharma brand analytics?
CPG and pharma brand analytics share similar goals—tracking market share, understanding competitive dynamics, explaining performance changes—but operate in different contexts.
CPG brand analytics focuses on retail sell-through, measured through syndicated POS data and retailer feeds. Performance is driven by distribution, shelf presence, pricing, and promotion. Competitive dynamics play out at the store level, often weekly.
Pharma brand analytics focuses on prescription volume (TRx, NBRx), measured through claims data and specialty pharmacy feeds. Performance is driven by HCP prescribing behavior, payer access, and patient adherence. Competitive dynamics involve clinical differentiation and formulary positioning.
The analytical frameworks transfer—share decomposition, competitive monitoring, root cause analysis—but the specific metrics, data sources, and business drivers differ significantly.
8. What's the relationship between brand performance and trade promotion effectiveness?
Brand performance and trade promotion are deeply connected. Promotions drive short-term velocity spikes that affect share. The effectiveness of those promotions—lift, incrementality, ROI—determines whether promotional share gains are profitable or just expensive volume.
A brand might gain share during promoted periods but lose it between promotions if the underlying franchise is weak. Or maintain flat share despite heavy promotion if competitors are promoting equally hard.
AI-powered analytics connects these perspectives—showing how promotional activity affects brand performance metrics, identifying whether share gains are promotion-driven or base-driven, and calculating the efficiency of promotional investment against brand goals.
Part 2: Share Analysis, Competitive Intelligence & Root Cause
Deep dive into share decomposition, competitive tracking, and understanding why metrics changed.
11. What is velocity and why does it matter for brand performance?
Velocity measures sales per point of distribution—how well your product sells in stores that carry it. If your product generates $200/week average in stores that stock it, that's your velocity.
Velocity matters because it's the purest measure of consumer demand at shelf. Distribution can be bought through trade investment, but velocity reflects whether consumers actually want the product.
High velocity earns shelf space—retailers reward products that turn inventory. Low velocity risks rationalization—retailers cut slow movers to make room for better performers.
Velocity trends signal brand health. Rising velocity indicates growing demand—consumers buying more frequently or in larger quantities. Declining velocity signals weakening demand—competitive losses, changing preferences, or execution problems at shelf.
12. How does AI help identify and respond to competitive threats?
Competitive threats emerge in several forms: share gains (competitor taking points from you), distribution gains (competitor expanding shelf presence), velocity improvements (competitor selling better at existing distribution), new item success (competitor launch gaining traction), and pricing moves (competitor adjusting price positioning).
Identifying threats requires continuous monitoring across all these dimensions—something that's impossible manually but straightforward for AI. Agentic monitoring flags significant competitive changes: "Competitor X gained 1.2 share points in the Northeast over the past 4 weeks, driven primarily by velocity improvement at Walmart."
Responding effectively requires understanding why the competitor is winning. If they're winning on price, respond with value messaging or promotion. If they're winning on distribution, respond with sales effort. If they're winning with a new product, respond with innovation or positioning.
AI transforms competitive intelligence from a quarterly scramble into continuous awareness—detecting threats weeks earlier and providing the context needed to respond effectively.
14. How do I monitor competitive pricing and promotional activity?
Competitive pricing monitoring tracks everyday prices, promoted prices, and price gaps between your products and competitors. This data typically comes from syndicated sources (Nielsen, Circana track average prices) and retailer-specific feeds (some retailers provide competitive shelf pricing).
Promotional activity monitoring tracks when competitors promote, at what depth, and with what tactics. Promotional intensity affects the competitive environment—a competitor that's promoting heavily creates different dynamics than one relying on everyday pricing.
AI-powered monitoring automates this tracking and identifies significant changes: "Competitor Y reduced everyday price by 8% at Target last week" or "Competitor Z promotional frequency increased 25% versus prior quarter."
Price and promotion signals often predict share movements. Catching these signals early enables proactive response rather than reactive scrambling after share has already shifted.
15. How does AI analyze new product launch performance?
New product analysis tracks launch trajectory across multiple dimensions: distribution build (how quickly are retailers stocking?), velocity performance (how well is it selling where available?), repeat purchase (are trial buyers coming back?), and source of volume (is growth coming from new buyers, competitor switching, or cannibalizing your own products?).
Each dimension tells a different story. Fast distribution with weak velocity means retailers are stocking but consumers aren't buying—potential problem. Strong velocity with slow distribution means consumers want it but retailers aren't convinced—sales opportunity.
AI automates new product tracking by monitoring these metrics continuously against benchmarks and plan. Alerts flag when launches are ahead or behind trajectory, enabling early intervention. "New Item X is tracking 30% below velocity plan at week 6—primarily driven by underperformance at Kroger and Albertsons."
AI also connects launch performance to marketing and trade investment, showing which activities are accelerating adoption and which aren't moving the needle.
16. How do I measure source of volume for new products?
Source of volume analysis identifies where new product sales come from—critical for understanding true incrementality. Sources include: new category buyers (people who weren't buying the category before), competitor switching (buyers moving from competitive products), intra-brand switching (buyers moving from your other products), and purchase acceleration (existing buyers buying more frequently).
Each source has different strategic value. Competitor switching and new category buyers grow your franchise. Intra-brand switching (cannibalization) just shifts volume within your portfolio. Purchase acceleration can be valuable but may be temporary.
AI measures source of volume by analyzing household-level panel data—tracking which households bought the new item and what they were buying before launch. This requires panel data integration (Numerator, NIQ) rather than just POS data.
17. How does AI connect brand health metrics to sales performance?
Brand health metrics—awareness, consideration, preference, equity—are typically measured through separate tracking studies that don't naturally connect to sales data. Connecting them requires aligning time periods, geographies, and sample definitions.
Once connected, the analysis examines correlation and lag. Do changes in awareness precede changes in share? Does equity improvement translate to velocity gains? How long is the lag between brand health movement and market performance response?
AI automates this connection by integrating brand tracking data with market performance data and identifying patterns. "Awareness increased 4 points in Q2, but share didn't respond until Q3—suggesting 1-quarter lag in your category."
This connection helps justify brand investment by demonstrating the link between equity-building activities and commercial results. AI continuously monitors both brand health and market performance, alerting when the relationship breaks down or when brand health trends suggest future performance risk.
18. What is price/volume/mix analysis and how does AI automate it?
Price/volume/mix (P/V/M) analysis decomposes revenue or share changes into component effects. Price effect captures the impact of price changes holding volume and mix constant. Volume effect captures the impact of unit sales changes holding price and mix constant. Mix effect captures the impact of shifting product mix (more premium vs. value products) holding total units and prices constant.
Traditionally, P/V/M analysis requires building custom Excel models for each question—a time-consuming process that limits how often it's performed.
AI automates P/V/M by building decomposition models continuously. Any revenue or share change can be instantly decomposed: "Q3 revenue growth of 5% breaks down as: +3% price effect, +1% volume effect, +1% mix effect." This makes P/V/M a standard lens on performance rather than an occasional special analysis.
19. How does AI help explain brand performance to leadership?
Leadership wants answers, not data. When share drops, they want to know why and what's being done about it. The challenge is translating complex multicausal performance dynamics into clear narratives under time pressure.
AI transforms leadership communication by: automating the "why" analysis that traditionally takes days, generating narrative explanations of performance drivers, and providing ready-made answers to predictable follow-up questions.
Effective leadership communication focuses on: what changed (the metric movement), why it changed (the decomposed drivers), what it means (implications for the business), and what we're doing (response and expected impact). AI can generate the first three automatically, freeing you to focus on the fourth.
AI-generated insights are consistent and auditable—leadership gets the same analytical rigor whether the question comes in a board meeting or a hallway conversation.
Part 3: Platform Evaluation & Implementation
Evaluate brand analytics platforms, understand implementation, and build the business case.
21. How does brand performance analytics integrate with existing systems?
Brand analytics complements rather than replaces existing systems. Nielsen Connect, Circana Unify, and retailer portals remain sources of record for market data. Internal systems continue managing brand tracking, trade spend, and commercial planning.
Integration works through data flows: brand analytics pulls from syndicated platforms, retailer feeds, and internal systems to create a unified analytical layer. It doesn't replace those sources but makes them more usable by eliminating manual reconciliation and adding automated analysis.
Outputs can feed existing workflows—decomposition insights pushed to presentation templates, competitive alerts routed to Slack or Teams, performance summaries embedded in review decks. The goal is augmentation, not replacement.
22. Can a brand manager prepare for a business review without waiting for analyst support?
Brand managers can self-serve the analysis that traditionally required analyst queues. Ask "Show me share performance versus last year for the premium segment" and get instant trends with decomposition. Ask "Why did we lose share at Target in Q3?" and get automated root cause analysis showing the distribution loss, velocity decline, or competitive factors driving the change. Ask "How are our new items performing versus launch benchmarks?" and get velocity trends, repeat purchase rates, and source-of-volume breakdowns.
The shift is from "request analysis from analyst, wait 3-5 days for report" to "get answer during the meeting where the question arose." Analysts still add value through strategic interpretation—but they're freed from the mechanical data assembly that consumed most of their time.
This changes business review dynamics. Brand managers arrive with insights already in hand, and the conversation shifts from "what happened" to "what should we do about it."
23. What does it cost when a competitive threat is detected 6 weeks late?
Late competitive detection compounds in three ways. First, share loss accelerates: a competitor gaining 0.3 points/month for 6 undetected weeks has taken nearly 2 points before you respond. Second, response effectiveness decreases: defensive actions work better when competitive momentum is still building versus after it's established. Third, internal credibility suffers: explaining to leadership why you didn't know about a competitive threat for 6 weeks undermines trust in your competitive intelligence.
The direct cost depends on your category and brand size, but for a $500M brand, 2 points of preventable share loss is $10M in annual revenue—plus the harder-to-quantify strategic damage of appearing flat-footed against competitors.
Early detection doesn't guarantee successful defense, but it dramatically improves the odds. You can't respond to what you don't see.
24. How do I demonstrate the value of faster answers to leadership questions?
The challenge with "faster answers" business cases is that leadership doesn't think of question-answering as a cost center—until you quantify it. Track for two weeks: every time someone asks "why did share change" or "what's driving competitor gains," note the question, who asked, how long until they got an answer, and what decisions waited for that answer.
Most teams discover 20+ hours per week of analyst time devoted to reactive leadership requests, plus delayed decisions that ripple through planning cycles. The business case reframes from "faster answers" (which sounds like efficiency) to "decisions made on current data" (which sounds like competitive advantage).
When leadership realizes they've been making decisions on month-old analysis because that's how long it takes to prepare, the value proposition crystallizes. The question shifts from "why invest in analytics?" to "why are we still operating blind?"
25. What is the best AI platform for CPG brand performance analytics?
The best AI platform for brand performance analytics needs five capabilities most tools lack.
First, multi-source data integration: seamless connection to Nielsen, Circana, retailer portals, panel data, and internal systems—with automated brand and market hierarchy harmonization.
Second, automated share decomposition: AI that breaks down share changes into distribution, velocity, price, and competitive effects without manual model-building.
Third, continuous competitive monitoring: agentic workflows that track competitor share, distribution, pricing, and new items—alerting when significant changes occur, not waiting for quarterly reviews.
Fourth, conversational access: brand managers asking "Why did share drop at Target?" in plain English and getting instant decomposition, not waiting for analyst reports.
Fifth, narrative generation: automated "why" explanations that translate data into the stories leadership needs, not just charts that require interpretation.
Tellius is purpose-built for CPG brand performance analytics and delivers all five capabilities.
26. Can AI decomposition handle unusual market events like supply disruptions or competitor recalls?
AI decomposition can detect and quantify unusual events, but it benefits from context. Supply disruptions show up as sudden velocity declines without corresponding distribution loss—the product is authorized but not selling. Competitor recalls appear as rapid competitive share decline concentrated in specific time periods and geographies.
The challenge is attribution: did your share gain because you did something right, or because a competitor had a recall? AI can identify that your share gain coincided with competitor decline and flag the correlation. Adding context—"Competitor X had a recall in Week 23"—allows more precise attribution.
Sophisticated decomposition handles event annotation: marking known events (supply issues, recalls, major competitive actions) so the model can isolate their effects. Without annotation, AI still shows the patterns; with annotation, it can quantify "how much of our Q3 gain was recall-driven versus organic?"
30. Who should be the first users of brand analytics, and what questions should I give them?
Start with 2-3 brand managers or commercial leads who ask "why" questions frequently—the ones who push back when share declines and aren't satisfied with surface explanations. Give them specific questions to test: "Why did share change at [specific retailer] last period?" (tests decomposition), "What's driving [competitor] gains in the [specific market]?" (tests competitive tracking), "How is [new product] performing versus launch benchmarks?" (tests new item tracking).
Success criteria: Did they get answers faster than their previous process? Did the answers reveal something they didn't already know? Did the insight change or confirm a decision?
The first users become internal advocates—or internal critics. Choose users who will engage seriously with the platform, not ones assigned arbitrarily. Their feedback shapes how the broader organization perceives the investment.
31. When should I trust the decomposition versus questioning the numbers?
Trust the decomposition when it aligns with what you know from the business and explains what you didn't understand. Question it when it conflicts with field intelligence, shows implausible driver attribution, or produces unstable results across similar time periods.
Specific red flags: decomposition claims velocity declined but your retail execution reports show strong in-store performance (possible data lag or misattribution); decomposition shows competitive share gains but you have no competitive intelligence supporting increased competitor activity (possible miscategorization); decomposition varies wildly between months without corresponding business events (possible model instability).
Healthy skepticism improves the platform—flag questionable results, investigate discrepancies, and feed corrections back to improve accuracy. The goal isn't blind trust; it's calibrated trust based on validated accuracy over time.
"We used to spend three days preparing for every business review—pulling data, building decomposition, chasing down the 'why.' Now I ask the question and get the answer. Leadership gets the same insight quality in real-time instead of waiting a week."

Stop Explaining What Changed. Start Explaining Why.
Every share movement has a story. AI-powered brand analytics tells it—instantly, automatically, and in the language leadership understands.
The Challenge Every Pharma Commercial Leader Faces
You're drowning in data from IQVIA, claims databases, CRM systems, and competitive intelligence platforms—yet when executives ask "Why did our numbers change?" the answer is always: "We'll need a few days to investigate."
The Problem Isn't Lack of Data — It's Lack of Insights
Traditional dashboards show what happened, not why
Root cause analysis takes days or weeks of manual investigation
Non-technical users can't explore data without submitting IT requests
Insights arrive too late to prevent revenue loss
Multiple tools and data sources create fragmented views
Field teams spend 40% of their time preparing reports instead of selling
Agentic Analytics Changes Everything
Deploy AI agents that work 24/7—continuously monitoring your business, automatically investigating changes, and proactively alerting you to risks and opportunities. From weeks of manual analysis to seconds of AI-generated insights. From reactive reporting to agentic intelligence. From data silos to unified, self-operating analytics.
Introducing Pharma Intelligence
Unified decision intelligence across your entire commercial operation
Pharma teams depend on fast, accurate insights across HCP targeting, field execution, market access, contracting, brand growth, patient services, and incentive compensation. Pharma Intelligence brings all these capabilities together—powered by AI analytics and agentic workflows—to help organizations unify data, explain performance, detect risks, and drive next-best actions across every commercial function.
📊 Analytics Solutions for Every Commercial Function
📊
Analytics Solutions for Every Commercial Function
Each hub addresses critical challenges with unified data, instant root cause analysis, and AI-powered insights. Choose your area to explore how we solve your specific pain points.

Field Force Sales Effectiveness
📝
34 Questions
⏱️
6,000 words
Pharma teams depend on fast, accurate insights across HCP targeting, field execution, market access, contracting, brand growth, patient services, and incentive compensation. Pharma Intelligence brings all these capabilities together—powered by AI analytics and agentic workflows—to help organizations unify data, explain performance, detect risks, and drive next-best actions across every commercial function.
Critical Capabilities:
HCP targeting & segmentation (AI-powered scoring)
Territory performance vs. potential (real-time)
Call quality & message effectiveness (NLP analysis)
Prescriber churn prediction (early warning alerts)
Pre-call planning (automated contextual briefs)

Brand Performance & KPIs
📝
31 Questions
⏱️
6,500 words
Transform business reviews and root cause analysis with instant TRx/NBRx explanations, automated market share decomposition, and complete narrative generation. Uncover hidden opportunities worth millions while reducing prep time from 2 weeks to 2 days—eliminating the endless Excel work and manual investigation cycle.
Critical Capabilities:
TRx/NBRx anomaly detection & auto-explanation
Market share decomposition (instant driver analysis)
Root cause analysis (multi-variable, seconds not days)
Business review automation (narrative + visuals)
Competitive intelligence (continuous tracking)

Market Access Performance
📝
30 Questions
⏱️
5,500 words
Track formulary changes, prior auth approval rates, and payer mix shifts with unified access intelligence—identifying exactly where coverage restrictions cost you scripts before they impact revenue. Get automated alerts on formulary movements, access barriers, and abandonment patterns with recommended interventions.
Critical Capabilities:
Formulary impact alerts (position change detection)
Prior authorization tracking (approval rate trends)
Payer mix dynamics (coverage shift analysis)
Abandonment prediction (access barrier identification)
Copay program ROI (effectiveness measurement)

Contracting & Payer Strategy
📝
30 Questions
⏱️
5,500 words
Optimize contract performance with unified tracking of rebate effectiveness, volume commitments, and ROI across all payer agreements. Model negotiation scenarios, measure contract impact in real-time, and identify which agreements deliver value and which underperform—with recommended actions before renewals.
Critical Capabilities:
Performance vs. expectations (continuous tracking)
Rebate effectiveness (automated optimization)
Scenario modeling (what-if negotiations)
Gross-to-net decomposition (contract-level)
Value-based outcomes (automated tracking)

HCP Targeting & Segmentation
📝
30 Questions
⏱️
5,500 words
Identify high-potential prescribers with AI-powered lookalike modeling, calculate physician lifetime value in real-time, and dynamically adjust segmentation as market conditions change. Find opportunities before competitors while optimizing targeting continuously—without manual deciling or static segment updates.
Critical Capabilities:
High-potential identification (AI-powered scoring)
Lookalike modeling (predictive targeting)
Prescriber LTV calculation (real-time updates)
Dynamic micro-segmentation (adaptive)
Acquisition optimization (prescriber journey)
⚡
Two Powerful Approaches to Analytics Transformation
⚡ Two Powerful Approaches to Analytics Transformation
Combine conversational interfaces for instant answers with agentic intelligence that works proactively—solving both immediate needs and long-term efficiency.

Conversational Analytics & AI Foundations
📝
25 Questions
⏱️
4,500 words
The foundation: Ask questions in plain English and get instant answers. Conversational interfaces democratize data access, automated root cause analysis explains why metrics moved, and predictive models forecast future performance. Essential AI capabilities that transform static dashboards into interactive intelligence.
Foundational AI Capabilities:
Conversational analytics (natural language queries)
Automated root cause analysis (driver decomposition)
Predictive modeling (prescription trend forecasting)
Machine learning (segmentation & targeting)
Unified data integration (IQVIA, CRM, claims, digital)

Agentic Analytics: AI Agents That Work 24/7
📝
25 Questions
⏱️
4,500 words
The evolution: AI agents work continuously 24/7—monitoring your business, automatically investigating anomalies, and proactively alerting you to risks and opportunities before you ask. Move from asking questions to receiving answers you didn't know you needed. This is what separates reactive analytics from agentic intelligence.
Agentic Capabilities:
24/7 monitoring (continuous surveillance)
Automatic anomaly investigation (self-initiated RCA)
Proactive risk alerts (before revenue impact)
Self-optimizing workflows (adaptive intelligence)
Automated business narratives (review generation)
Platform & Technology Questions
Understanding Pharma Intelligence and agentic analytics at the platform level
What is agentic analytics for pharmaceutical commercial operations
Agentic analytics represents the evolution from reactive reporting to proactive intelligence. Unlike traditional analytics where users must ask questions and wait for answers, agentic analytics deploys AI agents that work continuously—monitoring your business 24/7, automatically investigating anomalies, and proactively alerting you to risks and opportunities before you ask. In pharmaceutical commercial operations, this means AI agents track hundreds of metrics across brand performance, field execution, market access, and HCP engagement simultaneously. When meaningful changes occur—like a TRx decline, formulary restriction, or prescriber disengagement—agents automatically perform root cause analysis and deliver specific, actionable recommendations with full context.
How does Pharma Intelligence unify data across commercial functions?
Pharma Intelligence automatically integrates data from IQVIA (prescription trends, market share), Symphony (claims data), CRM systems (Veeva, Salesforce for field activity), payer databases (formulary status, prior auth rates), competitive intelligence, and internal systems. The platform creates a unified semantic layer that harmonizes these disparate sources, resolving HCP identities, aligning geographies, and standardizing metrics. This means field teams, brand managers, market access leaders, and contracting teams all work from the same single source of truth. When an AI agent detects a TRx decline, it can instantly correlate field activity, payer changes, competitive moves, and HCP prescribing patterns—insights impossible when data sits in silos.
What's the difference between AI analytics and agentic analytics?
AI analytics provides conversational interfaces and automated insights—you ask "Why did NBRx decline?" and get instant answers with root cause analysis. This is valuable and represents a major improvement over traditional BI. Agentic analytics goes further: AI agents work autonomously without human prompting. They continuously monitor your business, automatically detect meaningful changes, investigate root causes on their own, and proactively send you alerts with recommendations. Think of it as the difference between having a very smart assistant who answers your questions (AI analytics) versus having a team of analysts working 24/7 who investigate issues and bring you insights before you know to ask (agentic analytics). Most organizations need both layers working together.
What ROI can we expect from deploying agentic analytics?
Typical pharmaceutical companies see $10-17M in annual value creation per brand with 6-9 month payback periods and 1,700%+ first-year ROI. Value comes from four areas: analyst time savings (70-85% reduction, ~$645K annually), proactive issue detection (catching formulary changes, prescriber churn, access barriers 2-4 weeks earlier saves $3-4M), AI-identified opportunities (underserved segments, high-potential HCPs, contract optimization worth $5-10M), and improved forecasting accuracy ($2-3M in better resource allocation). Beyond quantifiable ROI, organizations report dramatically improved executive satisfaction, faster business reviews (2 weeks to 2 days), and field teams spending time selling instead of preparing reports. The platform essentially pays for itself within the first quarter through time savings alone.
How do AI agents work across field force, brand, and market access?
AI agents operate across all commercial functions simultaneously, detecting insights that span multiple teams. For example: an agent monitoring market access detects Aetna added step therapy requirements affecting 8,200 covered lives. It automatically investigates the brand impact (estimated -$2.3M TRx), identifies affected territories and HCPs, analyzes which field reps need to adjust messaging, and calculates the patient support program implications. Within minutes, the agent sends coordinated alerts to market access (escalate with payer), brand team (update forecasts), field leadership (prioritize affected HCPs), and patient services (expect abandonment increase). This cross-functional intelligence—impossible with siloed tools—enables coordinated responses that protect revenue.
How long does deployment take and what resources are needed?
Typical deployment takes 6-12 weeks from kickoff to full production. Week 1-3: Data integration (IQVIA, CRM, claims, payer sources). Week 4-6: Semantic layer configuration and pharma-specific metric definitions. Week 7-9: Agent deployment, alert configuration, and user training. Week 10-12: Optimization and rollout. Required resources: Executive sponsor (5% time), 2-3 business analysts (50% time during deployment), IT liaison (25% time for data access), and key business users for UAT. Post-deployment, platform is largely self-operating—AI agents handle monitoring and investigation automatically. Most organizations need only 1-2 FTEs for ongoing administration, far less than traditional BI platforms that require constant analyst support.
How does this compare to traditional pharma analytics platforms?
Traditional platforms (Tableau, Power BI, Qlik) require users to build dashboards, write SQL, and manually investigate every question. Pharma-specific platforms (IQVIA OCE, Veeva CRM Analytics) provide pre-built reports but still require manual analysis. Neither offers AI agents that work autonomously. With agentic analytics, AI agents continuously monitor and investigate automatically—no dashboard building, no SQL, no waiting. Conversational interfaces let anyone ask questions in plain English. Root cause analysis happens instantly, not in 3-5 days. Business reviews generate automatically. Most importantly: you receive insights proactively before issues impact revenue, rather than discovering problems in retrospective reports. Organizations typically keep existing platforms for specific use cases while Pharma Intelligence becomes the primary decision intelligence layer.
How Agentic Analytics Transforms Your Workflow
How Agentic Analytics Transforms Your Workflow
Unified Data Integration
Automatically connect and harmonize data from IQVIA, Symphony, CRM (Veeva, Salesforce), claims databases, competitive intelligence, and internal systems. No more manual data pulls or Excel wrestling.
Ask Questions in Plain English
Conversational analytics lets anyone ask questions like "Why did NBRx decline in the Northeast last month?" and receive instant answers with automated driver analysis. No SQL, no waiting for reports.
Deploy AI Agents
Agentic analytics agents work 24/7—continuously monitoring hundreds of metrics across all dimensions. When meaningful changes occur, agents automatically investigate root causes, quantify business impact, and send prioritized alerts with specific, actionable recommendations. No human prompting required.
Receive Proactive Insights & Recommendations
Get specific, prioritized alerts with context and next steps: "Prior auth denials increased 18% with Aetna in Q3. Estimated TRx impact: -$2.3M. Root cause: New step therapy requirement. Recommend: Escalate to market access team within 48 hours, review formulary status across all major payers." Know what to do, not just what happened.
Jump to Your Specific Challenge
AI agents answer your questions across three levels: foundational understanding, agentic capabilities, and business impact measurement.
🎯
Understanding Challenges & Best Practices
🎯 Understanding Challenges & Best Practices
🤖
AI Agents & Agentic Capabilities
🤖 AI Agents & Agentic Capabilities
💰
Platform Evaluation & Business Impact
💰 Platform Evaluation & Business Impact
Real Results from Deploying Agentic Analytics
How AI agents deliver measurable business impact across pharmaceutical commercial operations
Top 10 Pharma — Oncology Brand
85% reduction in monthly review prep with automated business narratives
AI agents identified $12M opportunity in underserved community oncology
Proactive formulary alerts detected risk 3 weeks earlier, saved $8M
ROI: 2,200% in first year with agentic monitoring
Specialty Pharma — Neurology
Analyst team reduced from 4 FTEs to 2 with agentic automation
15% NBRx improvement through AI-optimized HCP targeting
Agentic anomaly detection prevents $3-5M revenue loss annually
Payback period: 7 months from agent deployment
Mid-Size Pharma — Cardiovascular
AI agents generate weekly reviews in 2 hours vs. 2 days
Root cause analysis: instant vs. 3-5 days of manual investigation
Agents found $18M in hidden payer contract optimization opportunities
Executive satisfaction: 4.2 → 9.1/10 with agentic insights
Calculate Your ROI from Agentic Analytics
See what you could save by deploying AI agents across your commercial operations
Typical ROI from Agentic Analytics Deployment
Value from AI agents: Analyst time savings ($645K), proactive issue detection ($3-4M), AI-identified opportunities ($5-10M), improved forecasting ($2-3M), 24/7 monitoring & investigation (at fraction of human cost)
Breakthrough Ideas, Right at Your Fingertips
Dig into our latest guides, webinars, whitepapers, and best practices that help you leverage data for tangible, scalable results.

Assortment Optimization for CPG: Why Your Portfolio Decisions Are Running on Half the Available Intelligence
This blog argues that most CPG assortment decisions are running on “half a brain” because they rely almost entirely on structured data (POS, margin, distribution) while ignoring the unstructured side (reviews, retailer call notes, JBP decks, social listening, competitive docs). The result: repeated SKU rationalization cycles that cut tails but don’t fix the underlying portfolio problem, leaving shelf space vulnerable to private label and faster insurgent brands.
.png)
Unstructured Data Analytics for Pharma: Why Your Richest Intelligence Never Gets Used
Pharma’s most valuable insights live in unstructured content (CRM call notes, MSL interaction reports, payer meeting summaries, slide decks, emails/PDFs), but they rarely get analyzed at scale—so teams end up relying on skims and anecdotes; it then explains how Tellius uses AI agents to connect to those sources, extract entities (products, competitors, objections, sentiment), cluster recurring themes, and answer natural-language questions with supporting citations, highlighting a biotech example where analyzing 15,000+ MSL reports helped surface competitive signals faster and cut manual synthesis from weeks to same day.
.png)
Tellius AI Agents: Driving Real Analysis, Action, + Enterprise Intelligence
Tellius AI Agents transform business intelligence with dedicated AI squads that automate complex analysis workflows without coding. Join our April 17th webinar to discover how these agents can 100x enterprise productivity by turning questions into actionable insights, adapting to your unique business processes, and driving decisions with trustworthy, explainable intelligence.

PMSA Fall Symposium 2025 in Boston
Join Tellius at PMSA Oct 2–3 for two can’t-miss sessions: Regeneron on how they’re scaling GenAI across the pharma brand lifecycle, and a hands-on workshop on AI Agents for sales, HCP targeting, and access wins. Discover how AI-powered analytics drives commercial success.



.png)